跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Valcamp - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Valcamp
Approved
STANDARD
Valcamp
Novartis Farmaceutica S.P.A
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d79ca9b20359997c
Company
Novartis Farmaceutica S.P.A
Type
Standard
Approval Details
Approval Id
d79ca9b20359997c
Drug Approval Philippines Name
Valcamp
Product Name
Valcamp
Registration Number
DRP-4862-01
Brand Name
Valcamp
Generic Name
Amlodipine (as besilate) + Valsartan
Dosage Form
Film-Coated Tablet
Dosage Strength
5 mg / 80 mg
Manufacturer
Novartis Farmaceutica S.P.A
Importer
Sandoz Philippines Corporation
Distributor
Sandoz Philippines Corporation
Issuance Date
25 April 2025
Expiry Date
29 January 2028
Pharmacologic Category
Calcium Channel Blocker / Angiotensin II Receptor Blocker (ARB)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d79ca9b20359997c
Type
Standard
Back to Philippines FDA Approvals